Completed NA INTERVENTIONAL 2-arm NCT01729429

An Intervention Promoting HPV Vaccination in Safety-net Clinics

Sponsor: Cancer Prevention Research Institute of Texas

Conditions Human Papilloma Virus-Related Cervical Carcinoma

Interventions General Adolescent Vaccine Brochure HPV brochure, recall, reminders

Updated 7 times since 2017 Last updated: Mar 16, 2020 Started: May 31, 2010 Primary completion: Nov 30, 2012 Completion: Nov 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Human Papilloma Virus-Related Cervical Carcinoma, this trial is completed. The trial is conducted by Cancer Prevention Research Institute of Texas and has accumulated 7 data snapshots since 2010. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Oct 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Oct 2021 [monthly]

Completed NA
Apr 2020 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Jun 2018 — Apr 2020 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cancer Prevention Research Institute of Texas
Parkland Health and Hospital System
University of Texas Southwestern Medical Center

Data source: University of Texas Southwestern Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dallas, United States